Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc.

ARCT
Arcturus Therapeutics Holdings Inc.US flagNASDAQ Global Market
7.60
USD
-0.05
- -
216.02MMarket Cap

Arcturus Therapeutics Holdings Inc. (ARCT) Stock Splits

Learn about Arcturus Therapeutics Holdings Inc.'s most recent 1-for-7 basis stock split on November 16, 2017. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about Arcturus Therapeutics Holdings Inc.'s most recent stock split

Split Date: 2017-11-16
Split Ratio: 1:7
Price Before Split: $1.46
Price After Split: $0.21

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 7.00 times fewer shares (a 1:7 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Arcturus Therapeutics Holdings Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2017-11-161:7Yes$1.46$0.21

About Arcturus Therapeutics Holdings Inc.

Company overview and industry information

Arcturus Therapeutics Holdings Inc. (ARCT) operates in the Biotechnology industry. The recent 1-for-7 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Arcturus Therapeutics Holdings Inc. Summary

Last updated: 6/4/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.